SMALL CELL LUNG CANCER // FDA // PHARMAMAR // ZEPSYRE® . PharmaMar Has Filed New Drug Application for Zepsyre® ( Lurbinectedin ) with the FDA for the Treatment of Relapsed Small Cell Lung Cancer.